Hirntumoren im Kindesalter

  • J. E. A. Wolff
  • H. Jürgens
  • J. Kühl
  • P. Krauseneck
  • M. Bamberg

Zusammenfassung

Im Kindesalter ist das Gehirn ist die häufigste Lokalisation solider Tumoren. Die Inzidenz der Summe aller Hirntumoren pro 100000 Kinder/ Jahr ist 2,7, die Hälfte davon sind Astrozytome niedriggradiger Malignität. Der häufigste Gard-IV-Tumor ist das Medulloblastom.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Baldini M, Pession A, Basso G et al. (1991) N-myc and c-myc oncogenes amplification medulloblastoma. Tumori 77 (2): 118–121Google Scholar
  2. Bamberg M (1993) Zentralnervensystem. In: Dold U, Hermanek P, Höffken K, Sack K (Hrsg) Praktische Tumortherapie, 4. Aufl. Thieme, Stuttgart, S 565–594Google Scholar
  3. Bloom HJG, Thorton H, Schweisguth O (1982) SIOP medulloblastoma and high grade ependymoma therapeutic clinical trail: preliminary results (1975–1981). In: Raybauld C, Clement R, Lebreuli G, Bernard JL (eds) Pediatric oncology. Excerpta Medica, Amsterdam Oxford Pincerton, pp 309–322Google Scholar
  4. Caputy AJ, Mc Cullough DC, Manz HJ, Paterson K, Hammock MK (1987) A review of the factors influencing the prognosis of medulloblastoma. The importance of cell differentiation. J Neurosurg 66: 80–87Google Scholar
  5. Chang CH, Housepian EM, Herbert C (1969) An operative staging system and a megavolt radiotherapeutic technique for cerbellar medulloblastoma. Radiology 93: 1351–1359PubMedGoogle Scholar
  6. Duffner PK, Horowitz ME, Krischer JP et al. (1993) Postoperative chemotherapy and delayed radation in children less than three years of age with malignant brain tumor [see comments]. N Engl J Med 328(24: 1725–1731Google Scholar
  7. Evans AE, Jenkin RDT, Sposto R (1990) The treatment of medulloblastoma. Results of a prospective randomized trail of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 75: 72–78Google Scholar
  8. Kleihues P, Burger PD, Scheithauer BW (1993) The new WHO classification of brain tumors. Brain Pathol 3: 255–268PubMedCrossRefGoogle Scholar
  9. Krischer JP, Ragab AH, Kun L et al. (1991) Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study. J Neurosurg 74 (6): 905–909PubMedCrossRefGoogle Scholar
  10. Kühl J (1988) Chemotherapie bei Hirntumoren im Kindesalter–Literaturübersicht und Pilotprotokoll. Klin Pädiatr 200: 214–218PubMedCrossRefGoogle Scholar
  11. Laurent JP, Chang CH, Cohen ME (1985) A classificationsystem for primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa. Cancer 56 [7 Suppl]: 1807–1809PubMedCrossRefGoogle Scholar
  12. Packer RJ, Siegel KR, Sutton N et al. (1988) Efficacy of adjuvant chemotherapy for patients with poor-risk medulloblastoma: A preliminary report. Ann Neurol 24: 503–511PubMedCrossRefGoogle Scholar
  13. Packer RJ, Sutton LN, Goldwein JW et al. (1991) Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74 (3): 433–440PubMedCrossRefGoogle Scholar
  14. Scheurlen W, Petrasch K, Huppertz HI, Kuhl J (1993) Expression of mutant p53 protein in metastasizing medulloblastoma and PNET: a prognostic marker? [letter]. Am J Pediatr Hematol Oncol 15 (1): 137–138PubMedCrossRefGoogle Scholar
  15. Tait DM, Thorton-Jones, Bloom HJG, Lemerle J, Morris-Jones P (1990) Adjuvant chemotherapy for medulloblastoma: The first multi-centre control trail of the International Society of Pediatric Oncology ( SIOP I ). Eur J Cancer 26: 464–469Google Scholar
  16. Wasson JC, Saylor RL, Zelzer P et al. (1990) Oncogene amplification in pediatric brain tumors. Cancer Res 50 (10): 2987–2990PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • J. E. A. Wolff
  • H. Jürgens
  • J. Kühl
  • P. Krauseneck
  • M. Bamberg

There are no affiliations available

Personalised recommendations